JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB26247

Anti-Tetanus Toxoid antibody [5.1B8]

Be the first to review this product! Submit a review

|

(4 Publications)

Mouse Monoclonal TETX antibody. Suitable for ELISA and reacts with Clostridium tetani samples. Cited in 4 publications.

View Alternative Names

CTC_p60, tetX, Tetanus toxin, Tentoxylysin

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

5.1B8

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Clostridium tetani

Applications

ELISA

applications

Specificity

This antibody is specific for tetanus toxin and tetanus toxoid.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Clostridium tetani": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "1/12500", "ELISA-species-notes": "<p></p>" } } }

Product details

C. tetani toxoid injected in mice is not neutralized efficiently enough by administration of this antibody to allow rescue.

Properties and storage information

Form
Liquid
Purification notes
Protein A/G purified
Storage buffer
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS, 2.9% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Tetanus Toxoid often referred to as TT is an inactivated toxin used in vaccines to prevent tetanus. It originates from the bacterium Clostridium tetani which produces the neurotoxin tetanospasmin. This toxoid has a mass of approximately 150 kDa and is conventionally administered as a vaccine in humans and animals. It triggers an immune response without causing disease as it's a detoxified version of the toxin. Tetanus toxoid is expressed in a laboratory setting where it undergoes chemical treatment to eliminate toxicity while maintaining its antigenicity.
Biological function summary

Tetanus toxoid stimulates the immune system to produce antibodies against the active tetanus toxin tetanospasmin. It doesn't form part of any specific protein complexes but functions independently to evoke humoral immunity. The binding of these antibodies to tetanospasmin neutralizes its effect thereby preventing the inhibition of neurotransmitter release. This process is important for avoiding the spasms and muscle rigidity associated with tetanus. The immune response it provokes includes the activation of B cells which differentiate into plasma cells that produce anti-tetanus antibodies.

Pathways

Tetanus toxoid plays an integral part in the adaptive immune response. It functions within the humoral immune pathway by stimulating the Th2 response. This activation is associated with B-cell proliferation and differentiation into antibody-secreting cells which provide long-term immunity. The vaccine-related immune response connects to key immunological proteins like CD4+ T-helper cells which play a central role in modulating the immune system's response to vaccines.

The tetanus toxoid vaccine is directly related to preventing tetanus an acute often fatal infection marked by severe muscle contractions. By inducing immunity tetanus toxoid plays a preventive role against tetanospasmin-mediated dysfunction in the nervous system. Additionally the concept of herd immunity associated with tetanus prevention helps in protecting community members including those unvaccinated. No other direct protein associations in disorders are typically highlighted but successful immunization inherently aids in broader public health by reducing incidences of infection.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Tetanus toxin acts by inhibiting neurotransmitter release. It binds to peripheral neuronal synapses, is internalized and moves by retrograde transport up the axon into the spinal cord where it can move between postsynaptic and presynaptic neurons. It inhibits neurotransmitter release by acting as a zinc endopeptidase that catalyzes the hydrolysis of the '76-Gln-|-Phe-77' bond of synaptobrevin-2.
See full target information tetX

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Infection and immunity 84:2059-2075 PubMed27113360

2016

Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Applications

Unspecified application

Species

Unspecified reactive species

Guillaume Goyette-Desjardins,Cynthia Calzas,Tze Chieh Shiao,Axel Neubauer,Jennifer Kempker,René Roy,Marcelo Gottschalk,Mariela Segura

Bioconjugate chemistry 26:1041-53 PubMed25970207

2015

Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.

Applications

ELISA

Species

Mouse

Rashmi Jalah,Oscar B Torres,Alexander V Mayorov,Fuying Li,Joshua F G Antoline,Arthur E Jacobson,Kenner C Rice,Jeffrey R Deschamps,Zoltan Beck,Carl R Alving,Gary R Matyas

Journal of radiological protection : official journal of the Society for Radiological Protection 31:25-39 PubMed21346294

2011

Influence on the mouse immune system of chronic ingestion of 137Cs.

Applications

ELISA

Species

Unspecified reactive species

Jean-Marc Bertho,Marie-Cécile Faure,Sonia Louiba,Elie Tourlonias,Johanna Stefani,Baptiste Siffert,François Paquet,Isabelle Dublineau

Viral immunology 23:627-32 PubMed21142448

2010

The importance of antibody isotype in HIV-1 virus capture assay and in TZM-bl neutralization.

Applications

Unspecified application

Species

Unspecified reactive species

Kristina K Peachman,Lindsay Wieczorek,Gary R Matyas,Victoria R Polonis,Carl R Alving,Mangala Rao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com